Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 112

1.

Seminal plasma and semen amyloids enhance cytomegalovirus infection in cell culture.

Tang Q, Roan NR, Yamamura Y.

J Virol. 2013 Dec;87(23):12583-91. doi: 10.1128/JVI.02083-13. Epub 2013 Sep 11.

2.
3.

Liquefaction of semen generates and later degrades a conserved semenogelin peptide that enhances HIV infection.

Roan NR, Liu H, Usmani SM, Neidleman J, Müller JA, Avila-Herrera A, Gawanbacht A, Zirafi O, Chu S, Dong M, Kumar ST, Smith JF, Pollard KS, Fändrich M, Kirchhoff F, Münch J, Witkowska HE, Greene WC.

J Virol. 2014 Jul;88(13):7221-34. doi: 10.1128/JVI.00269-14. Epub 2014 Apr 16.

4.

Peptides released by physiological cleavage of semen coagulum proteins form amyloids that enhance HIV infection.

Roan NR, Müller JA, Liu H, Chu S, Arnold F, Stürzel CM, Walther P, Dong M, Witkowska HE, Kirchhoff F, Münch J, Greene WC.

Cell Host Microbe. 2011 Dec 15;10(6):541-50. doi: 10.1016/j.chom.2011.10.010.

5.

Effect of semen and seminal amyloid on vaginal transmission of simian immunodeficiency virus.

Münch J, Sauermann U, Yolamanova M, Raue K, Stahl-Hennig C, Kirchhoff F.

Retrovirology. 2013 Dec 5;10:148. doi: 10.1186/1742-4690-10-148.

6.

Characterization of the Influence of Semen-Derived Enhancer of Virus Infection on the Interaction of HIV-1 with Female Reproductive Tract Tissues.

Allen SA, Carias AM, Anderson MR, Okocha EA, Benning L, McRaven MD, Kelley ZL, Lurain J, Veazey RS, Hope TJ.

J Virol. 2015 May;89(10):5569-80. doi: 10.1128/JVI.00309-15. Epub 2015 Mar 4.

7.

Natural Seminal Amyloids as Targets for Development of Synthetic Inhibitors of HIV Transmission.

Sheik DA, Dewhurst S, Yang J.

Acc Chem Res. 2017 Sep 19;50(9):2159-2166. doi: 10.1021/acs.accounts.7b00154. Epub 2017 Aug 15.

8.

Cytomegalovirus replication in semen is associated with higher levels of proviral HIV DNA and CD4+ T cell activation during antiretroviral treatment.

Gianella S, Massanella M, Richman DD, Little SJ, Spina CA, Vargas MV, Lada SM, Daar ES, Dube MP, Haubrich RH, Morris SR, Smith DM; California Collaborative Treatment Group 592 Team.

J Virol. 2014 Jul;88(14):7818-27. doi: 10.1128/JVI.00831-14. Epub 2014 Apr 30.

9.

Aminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).

Roan NR, Sowinski S, Münch J, Kirchhoff F, Greene WC.

J Biol Chem. 2010 Jan 15;285(3):1861-9. doi: 10.1074/jbc.M109.066167. Epub 2009 Nov 6.

10.

Impact of seminal cytomegalovirus replication on HIV-1 dynamics between blood and semen.

Gianella S, Mehta SR, Strain MC, Young JA, Vargas MV, Little SJ, Richman DD, Kosakovsky Pond SL, Smith DM.

J Med Virol. 2012 Nov;84(11):1703-9. doi: 10.1002/jmv.23398.

11.

Interaction of fibronectin with semen amyloids synergistically enhances HIV infection.

Roan NR, Chu S, Liu H, Neidleman J, Witkowska HE, Greene WC.

J Infect Dis. 2014 Oct 1;210(7):1062-6. doi: 10.1093/infdis/jiu220. Epub 2014 Apr 8.

12.

Gallic Acid Is an Antagonist of Semen Amyloid Fibrils That Enhance HIV-1 Infection.

LoRicco JG, Xu CS, Neidleman J, Bergkvist M, Greene WC, Roan NR, Makhatadze GI.

J Biol Chem. 2016 Jul 1;291(27):14045-55. doi: 10.1074/jbc.M116.718684. Epub 2016 May 11.

13.

Enhancement of Ebola virus infection by seminal amyloid fibrils.

Bart SM, Cohen C, Dye JM, Shorter J, Bates P.

Proc Natl Acad Sci U S A. 2018 Jul 10;115(28):7410-7415. doi: 10.1073/pnas.1721646115. Epub 2018 Jun 25.

PMID:
29941593
14.

Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.

Usmani SM, Zirafi O, Müller JA, Sandi-Monroy NL, Yadav JK, Meier C, Weil T, Roan NR, Greene WC, Walther P, Nilsson KP, Hammarström P, Wetzel R, Pilcher CD, Gagsteiger F, Fändrich M, Kirchhoff F, Münch J.

Nat Commun. 2014 Apr 1;5:3508. doi: 10.1038/ncomms4508.

15.

Myricetin antagonizes semen-derived enhancer of viral infection (SEVI) formation and influences its infection-enhancing activity.

Ren R, Yin S, Lai B, Ma L, Wen J, Zhang X, Lai F, Liu S, Li L.

Retrovirology. 2018 Jul 16;15(1):49. doi: 10.1186/s12977-018-0432-3.

16.

SEVI, the semen enhancer of HIV infection along with fragments from its central region, form amyloid fibrils that are toxic to neuronal cells.

Elias AK, Scanlon D, Musgrave IF, Carver JA.

Biochim Biophys Acta. 2014 Sep;1844(9):1591-8. doi: 10.1016/j.bbapap.2014.06.006. Epub 2014 Jun 17.

PMID:
24948476
17.

Amyloid-binding small molecules efficiently block SEVI (semen-derived enhancer of virus infection)- and semen-mediated enhancement of HIV-1 infection.

Olsen JS, Brown C, Capule CC, Rubinshtein M, Doran TM, Srivastava RK, Feng C, Nilsson BL, Yang J, Dewhurst S.

J Biol Chem. 2010 Nov 12;285(46):35488-96. doi: 10.1074/jbc.M110.163659. Epub 2010 Sep 10.

18.

Seminal plasma accelerates semen-derived enhancer of viral infection (SEVI) fibril formation by the prostatic acid phosphatase (PAP248-286) peptide.

Olsen JS, DiMaio JT, Doran TM, Brown C, Nilsson BL, Dewhurst S.

J Biol Chem. 2012 Apr 6;287(15):11842-9. doi: 10.1074/jbc.M111.314336. Epub 2012 Feb 21.

19.

Genital Cytomegalovirus Replication Predicts Syphilis Acquisition among HIV-1 Infected Men Who Have Sex with Men.

Gianella S, Smith DM, Daar ES, Dube MP, Lisco A, Vanpouille C, Margolis L, Haubrich RH, Morris SR.

PLoS One. 2015 Jun 10;10(6):e0130410. doi: 10.1371/journal.pone.0130410. eCollection 2015.

20.

Disproportionately high semen shedding of HIV is associated with compartmentalized cytomegalovirus reactivation.

Sheth PM, Danesh A, Sheung A, Rebbapragada A, Shahabi K, Kovacs C, Halpenny R, Tilley D, Mazzulli T, MacDonald K, Kelvin D, Kaul R.

J Infect Dis. 2006 Jan 1;193(1):45-8. Epub 2005 Nov 21.

PMID:
16323130

Supplemental Content

Support Center